Nov 11, 2016Investigating the Potential Neurorestorative Effects of a Clinical Sigma-1 Receptor AgonistWorld Parkinson Congress 2016, Portland, ORV. Francardo, F. Bez, J. Sprouse, C. Missling, M.A. CenciView Poster
World Parkinson Congress 2016, Portland, ORV. Francardo, F. Bez, J. Sprouse, C. Missling, M.A. CenciView Poster
Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase IIb/III Data in The Journal of Prevention of Alzheimer’s Disease
New Phase IIb/III Clinical Data Demonstrates Over Three Years of Continuous Treatment with Oral Blarcamesine to Significantly Benefit Early Alzheimer’s Disease Patients
